NASDAQ
No price data available for this timeframe.
Neumora Therapeutics, Inc. Common Stock (NMRA) has a price/fcf ratio of -1.42x as of Monday, May 25, 2026. This represents a 92.88% increase compared to its 12-month average of -19.90x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.